vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and ALT5 Sigma Corp (ALTS). Click either name above to swap in a different company.

Alector, Inc. is the larger business by last-quarter revenue ($6.2M vs $5.4M, roughly 1.2× ALT5 Sigma Corp). On growth, ALT5 Sigma Corp posted the faster year-over-year revenue change (12.5% vs -88.5%). ALT5 Sigma Corp produced more free cash flow last quarter ($-7.2M vs $-184.1M).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

ALT5 Sigma Corp is a fintech firm focused on digital asset infrastructure and trading solutions. It operates regulated digital asset trading platforms for retail and institutional clients, primarily serving markets across North America, Europe, and the Asia-Pacific region. Its core offerings include spot and derivatives trading, digital asset custody, and secure settlement services.

ALEC vs ALTS — Head-to-Head

Bigger by revenue
ALEC
ALEC
1.2× larger
ALEC
$6.2M
$5.4M
ALTS
Growing faster (revenue YoY)
ALTS
ALTS
+101.0% gap
ALTS
12.5%
-88.5%
ALEC
More free cash flow
ALTS
ALTS
$176.9M more FCF
ALTS
$-7.2M
$-184.1M
ALEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALEC
ALEC
ALTS
ALTS
Revenue
$6.2M
$5.4M
Net Profit
$-381.5M
Gross Margin
40.9%
Operating Margin
-38.1%
Net Margin
-7100.2%
Revenue YoY
-88.5%
12.5%
Net Profit YoY
-1696.9%
-7249.1%
EPS (diluted)
$-5.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
ALTS
ALTS
Q4 25
$6.2M
$5.4M
Q3 25
$3.3M
$7.6M
Q2 25
$7.9M
$6.4M
Q1 25
$3.7M
$5.5M
Q4 24
$54.2M
$4.8M
Q3 24
$15.3M
$4.9M
Q2 24
$15.1M
$2.2M
Q1 24
$15.9M
$0
Net Profit
ALEC
ALEC
ALTS
ALTS
Q4 25
$-381.5M
Q3 25
$-34.7M
$49.0M
Q2 25
$-30.5M
$-9.1M
Q1 25
$-40.5M
$-2.9M
Q4 24
$-2.1M
$-5.2M
Q3 24
$-42.2M
$-822.0K
Q2 24
$-38.7M
$589.0K
Q1 24
$-36.1M
$-2.1M
Gross Margin
ALEC
ALEC
ALTS
ALTS
Q4 25
40.9%
Q3 25
34.6%
Q2 25
43.5%
Q1 25
47.0%
Q4 24
45.8%
Q3 24
47.8%
Q2 24
50.6%
Q1 24
Operating Margin
ALEC
ALEC
ALTS
ALTS
Q4 25
-38.1%
Q3 25
-1153.6%
-218.3%
Q2 25
-433.6%
-32.8%
Q1 25
-1216.5%
-39.4%
Q4 24
-13.4%
-40.8%
Q3 24
-315.7%
-14.8%
Q2 24
-302.4%
-112.2%
Q1 24
-275.0%
Net Margin
ALEC
ALEC
ALTS
ALTS
Q4 25
-7100.2%
Q3 25
-1063.4%
646.4%
Q2 25
-387.7%
-142.9%
Q1 25
-1101.6%
-51.9%
Q4 24
-3.8%
-108.7%
Q3 24
-275.2%
-16.6%
Q2 24
-256.4%
27.2%
Q1 24
-227.0%
EPS (diluted)
ALEC
ALEC
ALTS
ALTS
Q4 25
$-5.53
Q3 25
$-0.34
$0.29
Q2 25
$-0.30
$-0.49
Q1 25
$-0.41
$-0.18
Q4 24
$-0.02
$-0.35
Q3 24
$-0.43
$-0.06
Q2 24
$-0.40
$0.07
Q1 24
$-0.38
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
ALTS
ALTS
Cash + ST InvestmentsLiquidity on hand
$256.0M
$6.2M
Total DebtLower is stronger
$10.0M
$563.0K
Stockholders' EquityBook value
$30.6M
$1.2B
Total Assets
$293.2M
$1.2B
Debt / EquityLower = less leverage
0.33×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
ALTS
ALTS
Q4 25
$256.0M
$6.2M
Q3 25
$291.1M
$7.3M
Q2 25
$307.3M
$9.6M
Q1 25
$354.6M
$10.8M
Q4 24
$413.4M
$7.2M
Q3 24
$457.2M
$8.7M
Q2 24
$503.3M
$5.8M
Q1 24
$562.1M
$61.0K
Total Debt
ALEC
ALEC
ALTS
ALTS
Q4 25
$10.0M
$563.0K
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
$563.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
ALTS
ALTS
Q4 25
$30.6M
$1.2B
Q3 25
$57.7M
$1.6B
Q2 25
$71.2M
$26.1M
Q1 25
$94.6M
$21.8M
Q4 24
$126.8M
$12.4M
Q3 24
$118.9M
$20.2M
Q2 24
$150.6M
$22.9M
Q1 24
$178.9M
$3.8M
Total Assets
ALEC
ALEC
ALTS
ALTS
Q4 25
$293.2M
$1.2B
Q3 25
$335.3M
$1.6B
Q2 25
$356.4M
$94.7M
Q1 25
$408.3M
$78.0M
Q4 24
$468.3M
$75.7M
Q3 24
$516.0M
$74.9M
Q2 24
$570.7M
$75.4M
Q1 24
$635.5M
$18.6M
Debt / Equity
ALEC
ALEC
ALTS
ALTS
Q4 25
0.33×
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
0.05×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
ALTS
ALTS
Operating Cash FlowLast quarter
$-184.0M
$-7.2M
Free Cash FlowOCF − Capex
$-184.1M
$-7.2M
FCF MarginFCF / Revenue
-2951.3%
-133.4%
Capex IntensityCapex / Revenue
0.7%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-326.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
ALTS
ALTS
Q4 25
$-184.0M
$-7.2M
Q3 25
$-32.5M
$-8.7M
Q2 25
$-49.0M
$-5.2M
Q1 25
$-60.8M
$-1.5M
Q4 24
$-55.0M
$1.8M
Q3 24
$-50.7M
$4.2M
Q2 24
$-62.8M
$80.0K
Q1 24
$-61.3M
$-544.0K
Free Cash Flow
ALEC
ALEC
ALTS
ALTS
Q4 25
$-184.1M
$-7.2M
Q3 25
$-32.5M
Q2 25
$-49.1M
Q1 25
$-60.8M
Q4 24
$-55.2M
Q3 24
$-50.9M
Q2 24
$-63.1M
Q1 24
$-61.9M
FCF Margin
ALEC
ALEC
ALTS
ALTS
Q4 25
-2951.3%
-133.4%
Q3 25
-997.6%
Q2 25
-623.0%
Q1 25
-1655.0%
Q4 24
-101.8%
Q3 24
-332.1%
Q2 24
-418.6%
Q1 24
-389.3%
Capex Intensity
ALEC
ALEC
ALTS
ALTS
Q4 25
0.7%
0.2%
Q3 25
0.3%
Q2 25
0.1%
Q1 25
0.5%
Q4 24
0.3%
Q3 24
1.4%
Q2 24
2.2%
Q1 24
3.4%
Cash Conversion
ALEC
ALEC
ALTS
ALTS
Q4 25
Q3 25
-0.18×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.14×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons